Loading candles…
Bliss GVS Pharma Limited, incorporated in 1984, operates in the pharmaceutical industry specializing in the development, manufacturing, marketing, trading, and export of pharmaceutical formulations. The company's product range includes suppositories, pessaries, capsules, tablets, and syrups. With over 40 years of industrial expertise, Bliss GVS Pharma is vertically integrated, covering the entire value chain from research and development through to global distribution. It maintains a strong global presence, exporting to more than 60 countries including regions such as Sub-Saharan Africa and India. The company is notable as one of the world's largest manufacturers of suppositories and pessaries.
| Unaudited Results - FY25 | To consider and approve the Unaudited financial results for the period ended December 31, 2025 and the interim dividend, if any, for the financial year 2025-… | 10 Feb 2026 |
| Unaudited Results - Q2 & FY25 | To consider and approve the Unaudited Standalone and Consolidated financial results for the quarter and half year ended September 30, 2025 | 6 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 29 Jul 2025 |
| Intimation | Intimation of Board Meeting to consider Issuance of Sweat Equity Shares. | 12 May 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 12 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.